Skip to main content

Table 1 Primary and secondary end points of TERVA trial

From: Health coaching by telephony to support self-care in chronic diseases: clinical outcomes from The TERVA randomized controlled trial

Primary end points
▪ Provider-measured BP ≤140/85 mmHg
▪ Total cholesterol ≤4.5 mmol/L
▪ LDL ≤2.5 mmol/L
▪ Waist circumference ≤94 cm for men and ≤80 cm for women – later revised as 90 cm for women and 100 cm for men based on national guidelines
For congestive heart failure an additional end-point:
▪ Improved or maintained NYHA class
For participants with T2D:
▪ HbA1c ≤7%